0001387131-19-008131.txt : 20191031 0001387131-19-008131.hdr.sgml : 20191031 20191031165055 ACCESSION NUMBER: 0001387131-19-008131 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191029 FILED AS OF DATE: 20191031 DATE AS OF CHANGE: 20191031 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Long David W CENTRAL INDEX KEY: 0001642614 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37406 FILM NUMBER: 191184254 MAIL ADDRESS: STREET 1: 309 WAVERLEY OAKS RD., SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02452 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Corindus Vascular Robotics, Inc. CENTRAL INDEX KEY: 0001528557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 300687898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 309 WAVERLEY OAKS ROAD STREET 2: SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 508-653-3335 MAIL ADDRESS: STREET 1: 309 WAVERLEY OAKS ROAD STREET 2: SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02452 FORMER COMPANY: FORMER CONFORMED NAME: Your Internet Defender, Inc DATE OF NAME CHANGE: 20110824 4 1 long-form4_102919.xml OWNERSHIP DOCUMENT X0306 4 2019-10-29 1 0001528557 Corindus Vascular Robotics, Inc. CVRS 0001642614 Long David W 309 WAVERLEY OAKS RD., SUITE 105 WALTHAM MA 02452 0 1 0 0 CFO/Sr VP/Sec./Treasurer Non-qualified stock option (right to buy) 0.5499 2019-10-29 4 D 0 590048 3.73 D 2021-09-04 Common Stock 590048 0 D Non-qualified stock option (right to buy) 0.7507 2019-10-29 4 D 0 285773 3.5293 D 2024-06-04 Common Stock 285773 0 D Non-qualified stock option (right to buy) 1.46 2019-10-29 4 D 0 100000 2.82 D 2026-06-22 Common Stock 100000 0 D Non-qualified stock option (right to buy) 1.17 2019-10-29 4 D 0 100000 3.11 D 2027-04-06 Common Stock 100000 0 D Non-qualified stock option (right to buy) 1.05 2019-10-29 4 D 0 110000 3.23 D 2028-02-01 Common Stock 110000 0 D Non-qualified stock option (right to buy) 1.2 2019-10-29 4 D 0 110000 3.08 D 2029-01-31 Common Stock 110000 0 D On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent ("Merger Sub"), dated as of August 7, 2019 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). This option provided for vesting over a period of four years, with the first 25% vesting on September 5, 2012 and the remaining 75% vesting in 36 equal monthly installments at the end of every month thereafter. At the effective time of the Merger (the "Effective Time"), which occurred on October 29, 2019, each outstanding and unexercised option to purchase shares of the Issuer's common stock automatically converted into the right to receive a cash payment equal to the product of (i) the excess, if any, of $4.28 over the per share exercise price of such option, and (ii) the number of shares of the Issuer's common stock subject to such option as of the Effective Time, without interest and net of any applicable withholding taxes. This option provided for vesting over a period of four years, with the first 25% vesting on June 5, 2015 and the remaining 75% vesting in 36 equal monthly installments at the end of every month thereafter. This option provided for vesting over a period of four years, with the first 25% vesting on June 23, 2017 and the remaining 75% vesting in 36 equal monthly installments at the end of every month thereafter. This option provided for vesting over a period of four years, with the first 25% vesting on April 7, 2018 and the remaining 75% vesting in 36 equal monthly installments at the end of every month thereafter. This option provided for vesting over a period of four years, with the first 25% vesting on February 2, 2019 and the remaining 75% vesting in 36 equal monthly installments at the end of every month thereafter. This option provided for vesting over a period of four years, with the first 25% vesting on February 1, 2020 and the remaining 75% vesting in 36 equal monthly installments at the end of every month thereafter. /s/ David W. Long 2019-10-31